PI3Kdelta as a Novel Therapeutic Target in Pathological Angiogenesis. Wu W, Zhou G, Han H, Huang X, et al. Diabetes 2020;69:736-748.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu W, Zhou G, Han H, Huang X, et al. PI3Kdelta as a Novel Therapeutic Target in Pathological Angiogenesis. Diabetes 2020;69:736-748.
PMID: 31915155